Current best practices for operationalizing early phase global oncology trials require a shift in our approach. There are challenges associated with updated regulatory guidance, including Project Optimus, which requires maximum tolerated doses to be established earlier in the clinical development pathway. We are now seeing a shift toward multi-region clinical trials where the need for global reach is increasing. However, it is difficult to manage these trials effectively without having the right framework and research partnerships.
Watch our webinar moderated by Worldwide’s President of Oncology, Keya Watkins, as she and three other oncology experts delve into the important factors that must be considered for an effective early phase global oncology trial.
Best Practices For Operationalizing Global Ealy Phase Oncology Trials
Read more